Based on our previous findings that quinacrine can significantly induce DR5 protein levels and synergize with TRAIL to induce apoptosis (16), we combined quinacrine with TRAIL and investigated the antitumor activity of this drug combination in ovarian cancer models. The gene discussed is TNFRSF10B; the disease is ovarian cancer.